Imported yellow fever in a United States citizen

Clinical Infectious Diseases

Volumn 25, Issue 5, 1997, Pages 1143-1147

  McFarland, Joy M ^b   Baddour, Larry M ^b   Nelson, Jeffery E ^b   Elkins, Sandra K ^b   Craven, Robert B ^b   Cropp, Bruce C ^b   Chang, Gwong Jen ^b   Grindstaff, Alan D ^b   Craig, Allen S ^b   Smith, Russell J ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOPSY; BRAZIL; CASE REPORT; FATALITY; HOSPITAL ADMISSION; HUMAN; MALE; PRIORITY JOURNAL; RIVER; TOURISM; UNITED STATES; YELLOW FEVER;

EID: 0030731078     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516111     Document Type: Article

References (28)

1. Monath TP. Flaviviruses (yellow fever, dengue, dengue hemorrhagic fever, Japanese encephalitis, St. Louis encephalitis, tick-borne encephalitis). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:1465-74.
2. Robertson SE, Hull BP, Tomori O, Bele O, LeDue JW, Esteves K. Yellow fever: a decade of reemergence. JAMA 1996;276:1157-61.
3. Woodall J. From the Centers for Disease Control summary of a symposium on yellow fever. J Infect Dis 1981;144:87-91.
4. Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 1994. MMWR Morb Mortal Wkly Rep 1994;43:78-9.
5. Lewis JG, Chang G-J, Lanciotti RS, Trent DW. Direct sequencing of large flavivirus PCR products for analysis of genome variation and molecular epidemiological investigations. J Virol Methods 1992;38:11-24.
6. Chang J-G, Cropp BC, Kinney R, Trent DW, Gubler DJ. Nucleotide sequence variation of the envelope protein gene identifies two distinct genotypes of yellow fever virus. J Virol 1995;69:773-80.
7. Gould EA, Buckley A, Cane PA, Higgs S, Cammack N. Use of a monoclonal antibody specific for wild-type yellow fever virus to identify a wild-type antigenic variant in 17D vaccine pools. J Gen Virol 1989;70:1889-94.
8. Monath TP. Yellow fever: a medically neglected disease. Report on a seminar. Rev Infect Dis 1987;9:165-74.
9. Brès P. Benefit versus risk factors in immunization against yellow fever. International symposium on immunization: benefit vs. risk factors, Brussels 1978. Dev Biol Stand 1978;43:297-304.
10. Robbins FC, Mahmoud AAF, Warren KS. Algorithms in the diagnosis and management of exotic diseases. XIX. Major tropical viral infections: smallpox, yellow fever, and Lassa fever. J Infect Dis 1977;135:341-6.
11. Kerr JA. Liver pathology in yellow fever. Trans R Soc Trop Med Hyg 1973;67:882.
12. Francis TI, Moore DL, Edington GM, Smith JA. A clinicopathological study of human yellow fever. Bull WHO 1972;46:659-67.
13. Brown TM, Chang GJ, Cropp CB, Robbins KE, Psai TF. Detection of yellow fever virus by polymerase chain reaction. Clin Diag Virol 1994;2:41-51.
14. Chang GJ, Trent BW, Vomdam AV, Veergne E, Kinney RM, Mitchell CJ. An integrated target sequence and signal amplification assay, reverse transcriptase-PCR-enzyme linked immunosorbent assay, to detect and characterize flaviviruses. J Clin Microbiol 1994;32:477-83.
15. McCormick JB, King U, Webb PA, et al. Lassa fever: effective therapy with ribavirin. N Engl J Med 1986;314:20-6.
16. Huggins JW. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Rev Infect Dis 1989;11(suppl 4);S750-61.
17. Shin K, Nagai Y, Hirano C, et al. Survival rate in children with fulminant hepatitis improved by a combination of twice daily plasmapheresis and intensive conservative therapy. J Pediatr Gastroenterol Nutr 1989;9:163-4.
18. Edmond JC, Aran PP, Whitington PF, Broelsch CE, Baker AL. Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 1989;96:1583-8.
19. Bismuth H, Samuel D, Gugenheim J, et al. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 1987;107:337-41.
20. Reed W, Carroll J, Agramonte A. The etiology of yellow fever: an addition note. JAMA 1983;250:649-58.
21. Cook GC. Fatal yellow fever contracted at the hospital for tropical diseases, London, UK, in 1930. Trans R Soc Trop Med Hyg 1994;88:712-3.
22. Patterson DK. Yellow fever epidemics and mortality in the United States, 1693-1905. Soc Sci Med 1992;34:855-65.
23. Brandling-Bennett D, Pinheiro F. Infectious diseases in Latin America and the Caribbean: are they really emerging and increasing? Emerg Infect Dis 1996;2:59-61.
24. Anonymous. Yellow fever vaccination in the Americas. Pan Am Health Organ 1984;18:188-92.
25. World Health Organization. International travel and health vaccination requirements and health advise. Geneva: WHO, 1996.
26. ACP Task Force on Adult Immunization and Infectious Diseases Society of America. Guide for adult immunizations. 3rd ed. Philadelphia: American College of Physicians, 1994.
27. Farmer HF. Yellow fever and hookworm disease: impetus for public health in the southern United States. J Fla Med Assoc 1993;80:623-5.
28. Barros ML, Boecken G. Jungle yellow fever in the central Amazon [letter]. Lancet 1996;348:969-70.